SNDX
SNDX
US87164F1057
Syndax Pharmaceuticals, Inc.
Loading chart...

Valuation & History

Quarterly trend of key valuation metrics

Metric
Current (TTM) TTM Baseline
Q2 '26 30.06.2026
Q1 '26 31.03.2026
Q4 '25 31.12.2025
Market & Enterprise Value
Market Cap
1.51B EUR
1.95B EUR
2.07B EUR
1.84B EUR
Enterprise Value
1.54B EUR
2.2B EUR
2.28B EUR
2.05B EUR
Valuation Multiples
Trailing P/E
--
--
--
--
Forward P/E
-19.9x
--
--
--
Price to Sales
5.97x
7.73x
9.51x
12.04x
Price to Book
100.53x
129.07x
49.69x
28.41x
EV/Revenue
6.12x
8.73x
10.5x
13.42x
EV/EBITDA
-7.95x
--
--
--
Price to FCF (P/FCF)
--
--
--
--
EV/FCF
--
--
--
--
FCF Yield
-9.97%
-11.33%
-13.46%
-12.42%
ende